Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of Adjusted Doses of Darunavir/Ritonavir With Rifampicin in HIV-infected Volunteers

NCT03892161 is registered in ClinicalTrials.gov with University of Cape Town as lead sponsor.

NCT NCT03892161
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03892161 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of Adjusted Doses of Darunavir/Ritonavir With Rifampicin in HIV-infected Volunteers
Lead sponsor
University of Cape Town
Phase
Phase 1
Overall status
Terminated
Start date
April 12, 2018
Completion date
November 22, 2018
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections